Literature DB >> 8792400

Factors influencing the response to growth hormone in children with renal disease.

L Rees1, H Maxwell.   

Abstract

The effects of age, height velocity over the preceding year, glomerular filtration rate (GFR) and prednisolone dose on growth response have been assessed by single and multiple linear regression analysis in 23 prepubertal children [age, mean (SD), 8.2 (2.5) years] with chronic renal failure (CRF) and 16 prepubertal children [12.1 (2.3) years] with renal transplants treated for 1 year with recombinant human growth hormone (rhGH), 30 U/m2 per week. Height velocity [mean (SD), cm/year] increased from 4.7 (1.3) to 9.7 (2.1) (P < 0.0001) in the CRF group and 3.1 (1.6) to 7.3 (2.8) (P < 0.0001) in the transplant group. In the CRF group, there was a correlation between age and height velocity, both in the pretreatment year (r = -0.755, P < 0.0001) and during treatment (r = -0.421, P = 0.045). There was no correlation between pretreatment height velocity or GFR and response to rhGH. In the transplanted children height velocity during the treatment year correlated with age (r = -0.647, P = 0.007), prednisolone dose (r = -0.689, P = 0.003), GFR (r = 0.542, P = 0.030) and pretreatment height velocity (r = 0.655, P = 0.006). Multiple regression analysis showed prednisolone dose and age to be the most important predictors of response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792400     DOI: 10.1007/bf00866775

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

2.  Treatment of short stature in renal disease with recombinant human growth hormone.

Authors:  L Rees; S P Rigden; G Ward; M A Preece
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

3.  Growth and endocrine function after renal transplantation.

Authors:  L Rees; S A Greene; P Adlard; J Jones; G B Haycock; S P Rigden; M Preece; C Chantler
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

Review 4.  Wider indications for treatment with biosynthetic human growth hormone in children.

Authors:  P C Hindmarsh; N A Bridges; C G Brook
Journal:  Clin Endocrinol (Oxf)       Date:  1991-05       Impact factor: 3.478

5.  Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.

Authors:  A C Hokken-Koelega; T Stijnen; S M de Muinck Keizer-Schrama; J M Wit; E D Wolff; M C de Jong; R A Donckerwolcke; N C Abbad; A Bot; W F Blum
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

6.  Recombinant human growth hormone treatment in infants with chronic renal failure.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

7.  Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.

Authors:  H Maxwell; D R Nair; R N Dalton; S P Rigden; L Rees
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

8.  Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

Authors:  E Wühl; D Haffner; R Nissel; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

9.  Effects of recombinant human growth hormone on renal function in children with renal transplants.

Authors:  H Maxwell; R N Dalton; D R Nair; C Turner; A J Saunders; S P Rigden; L Rees
Journal:  J Pediatr       Date:  1996-02       Impact factor: 4.406

10.  Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.

Authors:  E Wühl; D Haffner; B Tönshoff; O Mehls
Journal:  Kidney Int Suppl       Date:  1993-10       Impact factor: 10.545

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.